Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$15.05
0.453.08%
al cierre: -
$15.15
0.10.66%
After hour: 4:19 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NOV Inc ha un obiettivo di prezzo di consenso pari a $18.27, stabilito in base alle ultime valutazioni degli analisti di 23. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, Stifel y RBC Capital il octubre 30, 2025, octubre 29, 2025 y octubre 29, 2025. Con un obiettivo di prezzo medio di $17.33 tra le Barclays, Stifel y RBC Capital, c'è un implicito 14.41% upside per NOV Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Barclays
Stifel
RBC Capital
Citigroup
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NOV
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/30/2025 | -7.59% | Barclays | $11 → $14 | Maintains | Underweight | |||
10/29/2025 | 25.41% | Stifel | $17 → $19 | Maintains | Buy | |||
10/29/2025 | 25.41% | RBC Capital | $17 → $19 | Maintains | Outperform | |||
10/08/2025 | -7.59% | Citigroup | $13 → $14 | Maintains | Neutral | |||
08/14/2025 | -7.59% | Piper Sandler | $16 → $14 | Maintains | Neutral | |||
07/30/2025 | 18.81% | RBC Capital | $19 → $18 | Maintains | Outperform | |||
07/30/2025 | -7.59% | Evercore ISI Group | $15 → $14 | Maintains | In-Line | |||
07/30/2025 | -0.99% | JP Morgan | $17 → $15 | Downgrade | Overweight → Neutral | |||
07/30/2025 | 12.21% | Susquehanna | $18 → $17 | Maintains | Positive | |||
07/30/2025 | 32.01% | Stifel | $22 → $20 | Maintains | Buy | |||
07/16/2025 | 45.21% | Stifel | $23 → $22 | Maintains | Buy | |||
07/01/2025 | 18.81% | Susquehanna | $19 → $18 | Maintains | Positive | |||
06/05/2025 | -33.99% | Wells Fargo | $11 → $10 | Maintains | Underweight | |||
05/16/2025 | -0.99% | Morgan Stanley | $18 → $15 | Maintains | Overweight | |||
05/01/2025 | -27.39% | Wells Fargo | $10 → $11 | Maintains | Underweight | |||
05/01/2025 | 5.61% | Piper Sandler | $18 → $16 | Maintains | Neutral | |||
04/30/2025 | -27.39% | Barclays | $13 → $11 | Maintains | Underweight | |||
04/30/2025 | 12.21% | JP Morgan | $20 → $17 | Maintains | Overweight | |||
04/30/2025 | 25.41% | RBC Capital | $20 → $19 | Maintains | Outperform | |||
04/15/2025 | 51.82% | Stifel | $25 → $23 | Maintains | Buy | |||
04/14/2025 | 25.41% | Susquehanna | $21 → $19 | Maintains | Positive | |||
04/10/2025 | -14.19% | Goldman Sachs | $16 → $13 | Maintains | Sell | |||
03/24/2025 | 45.21% | RBC Capital | $22 → $22 | Upgrade | Sector Perform → Outperform | |||
02/18/2025 | -14.19% | Barclays | $12 → $13 | Maintains | Underweight | |||
02/10/2025 | 18.81% | Piper Sandler | $17 → $18 | Maintains | Neutral | |||
02/06/2025 | 25.41% | Raymond James | $18 → $19 | Maintains | Outperform | |||
02/06/2025 | 45.21% | RBC Capital | $21 → $22 | Maintains | Sector Perform | |||
01/24/2025 | 18.81% | Morgan Stanley | $21 → $18 | Maintains | Overweight | |||
01/15/2025 | 18.81% | Evercore ISI Group | $25 → $18 | Downgrade | Outperform → In-Line | |||
12/18/2024 | -20.79% | Barclays | $16 → $12 | Maintains | Underweight | |||
12/10/2024 | 25.41% | ATB Capital | $19 → $19 | Downgrade | Outperform → Sector Perform | |||
11/11/2024 | 18.81% | Citigroup | $21 → $18 | Downgrade | Buy → Neutral | |||
11/04/2024 | -0.99% | Wells Fargo | $16 → $15 | Maintains | Underweight | |||
10/29/2024 | 5.61% | Barclays | $17 → $16 | Maintains | Underweight | |||
10/28/2024 | 45.21% | TD Cowen | $28 → $22 | Maintains | Buy | |||
10/28/2024 | 38.61% | Susquehanna | $22 → $21 | Maintains | Positive | |||
10/28/2024 | 58.42% | Stifel | $25 → $24 | Maintains | Buy | |||
10/16/2024 | 12.21% | Barclays | $20 → $17 | Maintains | Underweight | |||
10/14/2024 | 32.01% | B of A Securities | $22 → $20 | Maintains | Buy | |||
10/11/2024 | 65.02% | Stifel | $26 → $25 | Maintains | Buy | |||
10/11/2024 | 45.21% | Susquehanna | $26 → $22 | Maintains | Positive | |||
10/10/2024 | 32.01% | BMO Capital | $22 → $20 | Maintains | Market Perform | |||
10/03/2024 | 38.61% | Citigroup | $24 → $21 | Maintains | Buy | |||
10/03/2024 | 45.21% | JP Morgan | $23 → $22 | Maintains | Overweight | |||
09/25/2024 | 5.61% | Wells Fargo | $20 → $16 | Downgrade | Equal-Weight → Underweight | |||
09/16/2024 | 51.82% | Morgan Stanley | $25 → $23 | Maintains | Overweight | |||
07/30/2024 | 32.01% | Barclays | $17 → $20 | Maintains | Underweight | |||
07/29/2024 | 84.82% | TD Cowen | $27 → $28 | Maintains | Buy | |||
07/29/2024 | 58.42% | RBC Capital | $24 → $24 | Reiterates | Sector Perform → Sector Perform | |||
07/26/2024 | — | Benchmark | — | Reiterates | → Hold | |||
07/15/2024 | 45.21% | B of A Securities | $24 → $22 | Maintains | Buy | |||
07/15/2024 | 32.01% | Piper Sandler | $22 → $20 | Maintains | Neutral | |||
04/29/2024 | 71.62% | TD Cowen | $27 → $26 | Maintains | Buy | |||
04/08/2024 | 71.62% | Susquehanna | → $26 | Maintains | Positive | |||
02/20/2024 | 45.21% | Piper Sandler | $25 → $22 | Maintains | Neutral | |||
02/06/2024 | 58.42% | RBC Capital | $24 → $24 | Reiterates | Sector Perform → Sector Perform | |||
02/05/2024 | 71.62% | Stifel | $28 → $26 | Maintains | Buy | |||
02/05/2024 | 65.02% | Raymond James | $28 → $25 | Maintains | Outperform | |||
01/16/2024 | — | Benchmark | — | Downgrade | Buy → Hold | |||
12/12/2023 | 91.42% | TD Cowen | $28 → $29 | Maintains | Outperform | |||
12/08/2023 | 65.02% | JP Morgan | → $25 | Upgrade | Neutral → Overweight | |||
10/30/2023 | 58.42% | RBC Capital | $23 → $24 | Maintains | Sector Perform | |||
10/30/2023 | 91.42% | Raymond James | $28 → $29 | Maintains | Outperform | |||
10/17/2023 | 65.02% | Morgan Stanley | $24 → $25 | Maintains | Overweight | |||
10/03/2023 | 38.61% | Wells Fargo | $20 → $21 | Maintains | Equal-Weight | |||
08/09/2023 | 18.81% | Goldman Sachs | $16 → $18 | Maintains | Sell | |||
08/01/2023 | 58.42% | Morgan Stanley | $22 → $24 | Maintains | Overweight | |||
08/01/2023 | 71.62% | Citigroup | $21 → $26 | Maintains | Buy | |||
07/31/2023 | 32.01% | Piper Sandler | $21 → $20 | Maintains | Neutral | |||
07/31/2023 | 58.42% | Morgan Stanley | $22 → $24 | Maintains | Overweight | |||
07/31/2023 | 84.82% | Benchmark | → $28 | Reiterates | Buy → Buy | |||
07/31/2023 | 71.62% | Citigroup | $21 → $26 | Maintains | Buy | |||
07/31/2023 | 84.82% | Raymond James | $27 → $28 | Maintains | Outperform | |||
07/28/2023 | 32.01% | Wells Fargo | $18 → $20 | Maintains | Equal-Weight | |||
07/18/2023 | 38.61% | Citigroup | $22 → $21 | Maintains | Buy | |||
07/17/2023 | 45.21% | Morgan Stanley | $22 → $22 | Reiterates | Overweight → Overweight | |||
07/14/2023 | 32.01% | Capital One | → $20 | Initiates | → Equal-Weight | |||
07/14/2023 | 78.22% | Raymond James | $29 → $27 | Maintains | Outperform | |||
06/13/2023 | 5.61% | Goldman Sachs | $17 → $16 | Maintains | Sell | |||
06/02/2023 | 45.21% | Citigroup | $23 → $22 | Maintains | Buy | |||
05/01/2023 | 38.61% | Piper Sandler | $22 → $21 | Maintains | Neutral | |||
05/01/2023 | 32.01% | Barclays | $25 → $20 | Maintains | Equal-Weight | |||
04/18/2023 | 45.21% | Morgan Stanley | $24 → $22 | Maintains | Overweight | |||
04/05/2023 | 51.82% | Citigroup | $25 → $23 | Maintains | Buy | |||
02/08/2023 | 78.22% | Cowen & Co. | $26 → $27 | Maintains | Outperform | |||
02/08/2023 | 91.42% | Susquehanna | $26 → $29 | Maintains | Positive | |||
02/08/2023 | 45.21% | Piper Sandler | → $22 | Maintains | Neutral | |||
02/08/2023 | 78.22% | RBC Capital | → $27 | Reiterates | → Sector Perform | |||
01/19/2023 | 84.82% | Benchmark | → $28 | Initiates | → Buy | |||
01/04/2023 | 58.42% | Morgan Stanley | $21 → $24 | Upgrade | Equal-Weight → Overweight | |||
11/07/2022 | 65.02% | Wells Fargo | $16 → $25 | Upgrade | Underweight → Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NOV (NOV)?
El último precio objetivo de NOV (NYSE:NOV) fue comunicado por Barclays el octubre 30, 2025. La firma de analistas fijó un precio objetivo para $14.00 que espera NOV a fall dentro de 12 meses (un posible -7.59% downside). 33 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NOV (NOV)?
La última calificación de analistas para NOV (NYSE:NOV) fue proporcionada por Barclays, y NOV mantuvo su underweight calificación.
¿Cuándo se produjo la última revisión al alza de NOV (NOV)?
La última revisión al alza de NOV Inc se produjo en marzo 24, 2025, cuando RBC Capital elevó su precio objetivo a $22. RBC Capital anteriormente tenía a sector perform para NOV Inc.
¿Cuándo fue la última revisión a la baja de NOV (NOV)?
La última revisión a la baja de NOV Inc se produjo en julio 30, 2025, cuando JP Morgan cambió su precio objetivo de $17 a $15 para NOV Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NOV (NOV)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NOV, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NOV se registró el octubre 30, 2025, por lo que la próxima calificación estará disponible en torno al octubre 30, 2026.
¿Es correcta la calificación de los analistas sobre NOV (NOV)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NOV (NOV) fue un mantuvo con un precio objetivo de $11.00 a $14.00. El precio actual al que cotiza NOV (NOV) es de $15.15, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.